Dr. Reddy’s launches drug for cold in the U.S


Dr. Reddy’s Laboratories has launched an over-the-counter store brand equivalent of Mucinex D extended release tablets in two strengths in the U.S. market. Announcing that the US Food and Drug Administration had approved the product, DRL said the Mucinex D brand and store brands had combined U.S. sales of around $71 million MAT (moving annual total) for 12 months ended May.Mucinex is a trademark of RB HEALTH (US) LLC. Senior vice-president and head of U.S. OTC and specialty Rx divisions Milan Kalawadia said the company is growing its portfolio in the cough, cold and allergy category and such launches “illustrate our continued commitment to the OTC business.”

A combination drug, containing guaifenesin and pseudoephedrine Hcl, Mucinex D is used to help loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive.

It also helps in temporarily relieving nasal congestion due to common cold, hay fever and upper respiratory allergies; temporarily restore freer breathing through the nose; promote nasal and/or sinus drainage; and temporarily relieve sinus congestion and pressure.

In a release on Tuesday, Dr. Reddy’s said OTC Guaifenesin 1200 mg and Pseudoephedrine HCl 120 mg is available in 24-count packages, while its OTC Guaifenesin 600 mg and Pseudoephedrine HCl 60 mg is available in 18 and 36 count packages.

Why you should pay for quality journalism - Click to know more

Recommended for you
This article is closed for comments.
Please Email the Editor

Printable version | Feb 24, 2020 2:22:25 AM |

Next Story